United States · FDA National Drug Code directory
Marvona-25 SUIK
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 87063-079_491b452c-8e01-dfc0-e063-6394a90a3427
- Product NDC
- 87063-079
- Form
- INJECTION, SOLUTION
- Composition / generic term
- Bupivacaine Hydrochloride
- Labeler
- Asclemed USA, Inc.
- Marketing category
- UNAPPROVED DRUG OTHER
- Marketing start / end (source format)
- 20260124
- Source listing expiry
- 20271231
Source-listed ingredients
- BUPIVACAINE HYDROCHLORIDE — 2.5 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, SINGLE-DOSE in 1 CARTON (87063-079-01) / 10 mL in 1 VIAL, SINGLE-DOSE · 87063-079-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →